| scholarly article | Q13442814 |
| P2093 | author name string | Raouf A Khalil | |
| Sajjadh M J Ali | |||
| P2860 | cites work | Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies | Q81236313 |
| Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression | Q81411178 | ||
| Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood | Q81432957 | ||
| Pre-eclampsia | Q81446389 | ||
| Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia | Q81813556 | ||
| First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia | Q81931104 | ||
| Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma | Q83351931 | ||
| Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by L-NAME in rats | Q84560562 | ||
| Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia | Q88149610 | ||
| STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trondelag Health Study | Q24339395 | ||
| VEGF inhibition and renal thrombotic microangiopathy | Q24632792 | ||
| Primary, secondary, and tertiary prevention of pre-eclampsia | Q28176253 | ||
| Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 | Q28221171 | ||
| Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies | Q28222709 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression | Q28573546 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| [Ca(2+)](i) signaling in renal arterial smooth muscle cells of pregnant rat is enhanced during inhibition of NOS. | Q31732247 | ||
| STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas | Q33392665 | ||
| Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy | Q33665037 | ||
| Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy | Q33793455 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy | Q34051646 | ||
| Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment | Q34565651 | ||
| Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia | Q34656275 | ||
| Chymotrypsin-like protease (chymase) mediates endothelial activation by factors derived from preeclamptic placentas | Q34707016 | ||
| STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation | Q34735623 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| Enhanced expression of Ang-(1-7) during pregnancy | Q35845564 | ||
| Abnormal placentation and the syndrome of preeclampsia | Q35941005 | ||
| Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn | Q36105461 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| The role of the immune system in preeclampsia | Q36791219 | ||
| The glomerular injury of preeclampsia | Q36883342 | ||
| Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. | Q36948563 | ||
| Preeclampsia and angiogenic imbalance | Q36971766 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. | Q37072792 | ||
| Altered global gene expression in first trimester placentas of women destined to develop preeclampsia | Q37155561 | ||
| Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats | Q37200099 | ||
| Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. | Q37293822 | ||
| Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers | Q37298028 | ||
| Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia | Q37313333 | ||
| The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy | Q37328814 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade | Q37459545 | ||
| Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia | Q37868905 | ||
| Human-specific expression of Siglec-6 in the placenta | Q38300677 | ||
| Genetic variants in pre-eclampsia: a meta-analysis. | Q39489329 | ||
| Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study | Q40802999 | ||
| Intolerance to volume expansion: a theorized mechanism for the development of preeclampsia | Q40847041 | ||
| Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta | Q42484206 | ||
| Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats | Q42515767 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro | Q43664278 | ||
| Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats | Q43888051 | ||
| Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure | Q44185600 | ||
| Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia | Q44218040 | ||
| Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome | Q44401791 | ||
| The M235T variant of the angiotensinogen gene is related to development of self-reported hypertension during pregnancy: the Prospect-EPIC cohort study | Q44632633 | ||
| Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats | Q44715072 | ||
| Paternal and maternal components of the predisposition to preeclampsia | Q45084472 | ||
| Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. | Q45961711 | ||
| GRP78 as a marker of pre-eclampsia: an exploratory study. | Q45989281 | ||
| TNF α G308A gene polymorphism has an impact on renal function, microvascular permeability, organ involvement and severity of preeclampsia. | Q46315711 | ||
| Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia. | Q46333261 | ||
| Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks | Q46334260 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia | Q46440312 | ||
| Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition | Q46454719 | ||
| Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins | Q46789404 | ||
| Uterine vascular function in a transgenic preeclampsia rat model | Q46808246 | ||
| Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites | Q46886600 | ||
| Angiotensinogen genotype and plasma volume in nulligravid women | Q47703792 | ||
| Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery | Q47836743 | ||
| Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro | Q47884975 | ||
| Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia | Q47915288 | ||
| Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. | Q51767630 | ||
| Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. | Q53538854 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Systemic hemodynamics and regional blood flow during chronic nitric oxide synthesis inhibition in pregnant rats. | Q54148277 | ||
| Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. | Q54485033 | ||
| Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? | Q54551217 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| Soluble fms-like Tyrosine Kinase 1 | Q56619509 | ||
| Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2 | Q57670256 | ||
| Polymorphisms of FAS and FAS ligand genes in preeclamptic women | Q61851339 | ||
| Plasma level of soluble c-Met is tightly associated with the clinical risk of preeclampsia | Q61964340 | ||
| Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis | Q73426782 | ||
| Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats | Q74518978 | ||
| Nitric oxide production with preeclampsia | Q74601245 | ||
| Is preeclampsia an infectious disease? | Q77153770 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| Activation of leukocytes during the uteroplacental passage in preeclampsia | Q77513220 | ||
| Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression | Q77684136 | ||
| Microalbuminuria after pregnancy complicated by pre-eclampsia | Q77799245 | ||
| Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia | Q78220660 | ||
| Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin | Q79278420 | ||
| Renal angiotensin-II receptors expression changes in a model of preeclampsia | Q80238082 | ||
| Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension | Q80361560 | ||
| Serum levels of interleukin-6, interleukin-1beta and human chorionic gonadotropin in pre-eclamptic and normal pregnancy | Q80454204 | ||
| Circulating angiogenic factors in singleton vs multiple-gestation pregnancies | Q80564650 | ||
| Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia | Q80812036 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | maternal health | Q6786626 |
| P304 | page(s) | 1495-1515 | |
| P577 | publication date | 2015-08-21 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy | |
| P478 | volume | 19 |
| Q48133399 | Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks. |
| Q92528205 | Association of circulating saturated fatty acids with the risk of pregnancy-induced hypertension: a nested case-control study |
| Q51000408 | Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy. |
| Q38670775 | Differential responses of mesenteric arterial bed to vasoactive substances in L-NAME-induced preeclampsia: Role of oxidative stress and endothelial dysfunction |
| Q38720237 | Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α. |
| Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
| Q47223491 | Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease |
| Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q95840724 | Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function |
| Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q88609514 | Neonatal outcomes of extremely preterm infants exposed to maternal hypertension and cigarette smoking |
| Q54119733 | Placental Growth Factor Reverses Decreased Vascular and Uteroplacental MMP-2 and -9 and increased MMP-1 and -7 and Collagen I and IV in Hypertensive Pregnancy. |
| Q57815317 | Response Gene to Complement 32 Maintains Blood Pressure Homeostasis by Regulating α-Adrenergic Receptor Expression |
Search more.